cGMP CDMO providing custom development and manufacturing of small-molecule APIs, HPAPIs and intermediates for pharmaceutical and biotech companies. Capabilities span early-to-commercial supply (1–1000+ kg to multi-ton scale), scale-up, R&D, flow chemistry and HPAPI expertise.